STAT+: Key data on a new class of cardio drugs are coming
Stat News • 8/26/2026
Summary
Key data on a new class of cardio drugs is expected to be released. The news also includes information about GSK's shingles vaccine and a new financial investment in women's health, along with additional biotech updates from The Readout.
Advertisement
Lindy Score Breakdown (V4.2)
2h
Age
1
Sources
from cluster
2
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier97% (0.5^2/48)
Hero EligibleYes
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Medicaid transgender care rule sets precedent that could restrict coverage of other drugs
Stat News • 2 days ago
STAT+: Turkish antitrust authorities probe Teva for allegedly gaming the patent system, disparaging rival drugs
Stat News • 1 day ago
STAT+: FDA digital health leader promises generative AI regulatory guidance is coming
Stat News • 2 days ago
STAT+: FDA approves new pancreatic cancer drug expected to usher in new era of treatment
Stat News • Today
STAT+: When it comes to women’s health, money talks
Stat News • Today
STAT+: Public-sector purgatory, and a union-hospital fight
Stat News • 2 days ago
STAT+: AI is good at catching drug theft at hospitals, but only when humans do their part
Stat News • 1 day ago
STAT+: Comments on OMB research rule mysteriously removed from federal website
Stat News • 1 day ago
STAT+: Lady Gaga and her fiancé launch a biotech startup
Stat News • 2 days ago
STAT+: How Trump’s funding cuts are reshaping the health system
Stat News • 1 day ago